Life Science Intelligence (LSI) announced today that more than 25 medical device companies with emerging technologies will be showcased at their upcoming Emerging Medical Technologies Spotlight – an online meeting being held on August 11, 2010 at 11 a.m. Eastern, sponsored by Rutan, with additional sponsorships available.

The program will feature select privately-held companies that are:
At various stages of development

LSI’s Emerging Medical Technologies Spotlight is a travel-free online conference, which serves as a convenient forum for medical technology innovators, investors, and dealmakers to connect and collaborate from their desktops. Registered attendees and select LSI members, which include the top medtech dealmaking companies and investment firms, will have an opportunity to quickly and efficiently preview these innovative companies and then selectively network with the CEOs.
Attendees to the meeting will get online access to:

LSI’s online venue provides CEOs of emerging medical device technologies with a secure platform to efficiently share their business development and investment opportunities to a prominent investment and partnering audience. Interested entrepreneurs may apply to present for the August 11th meeting.

Contact: Life Science Intelligence Scott Pantel, 1-714-847-3540 scott@LifeScienceIntelligence.comAbout OrthoAccel Technologies, Inc.
Based in Houston, Texas, OrthoAccel Technologies, Inc. is a privately owned medical device company currently engaged in the development, manufacturing, and marketing of products to enhance dental care and orthodontic treatment.

About the AcceleDent System
AcceleDent represents the first clinical approach to safely accelerate orthodontic tooth movement via modulating biology. The device has been studied clinically and applies gentle pulsing forces in combination with standard orthodontics to move teeth faster through accelerated bone remodeling. Importantly, the device works complementary with all existing orthodontic technologies. AcceleDent is neither FDA cleared nor FDA approved; it is currently investigational only in the United States. More information can be found at www.acceledent.com and www.acceledent.co.uk or requested via info@orthoaccel.com